ENDRA Life Sciences Inc. (NDRA)

NASDAQ: NDRA · Real-Time Price · USD

3.780

+0.695 (22.53%)

At close: Apr 23, 2025, 4:00 PM

3.570

-0.210 (-5.56%)

After-hours: Apr 23, 2025, 7:50 PM EDT

ENDRA Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Selling, General & Admin	7.63	5.52	6.6	6.02	5.58	Upgrade
Research & Development	3.19	5	6.55	5.48	5.92	Upgrade
Operating Expenses	10.82	10.52	13.16	11.5	11.5	Upgrade
Operating Income	-10.82	-10.52	-13.16	-11.5	-11.5	Upgrade
Interest Expense	-	-	-	-	-0.23	Upgrade
Other Non Operating Income (Expenses)	-0.69	0.46	-0.02	-0.04	0.01	Upgrade
EBT Excluding Unusual Items	-11.51	-10.06	-13.18	-11.54	-11.73	Upgrade
Other Unusual Items	-	-	-	0.31	-	Upgrade
Pretax Income	-11.51	-10.06	-13.18	-11.23	-11.73	Upgrade
Net Income	-11.51	-10.06	-13.18	-11.23	-11.73	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	0.12	0.4	Upgrade
Net Income to Common	-11.51	-10.06	-13.18	-11.35	-12.12	Upgrade
Shares Outstanding (Basic)	0	-	-	-	-	Upgrade
Shares Outstanding (Diluted)	0	-	-	-	-	Upgrade
EPS (Basic)	-56.94	-	-	-	-	Upgrade
EPS (Diluted)	-56.94	-	-	-	-	Upgrade
Free Cash Flow	-7.42	-9.58	-12.97	-11.17	-10.82	Upgrade
Free Cash Flow Per Share	-36.70	-	-	-	-	Upgrade
EBITDA	-10.77	-10.4	-13.06	-11.38	-11.4	Upgrade
D&A For EBITDA	0.05	0.12	0.1	0.12	0.1	Upgrade
EBIT	-10.82	-10.52	-13.16	-11.5	-11.5	Upgrade

Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q